Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.18 USD | +0.57% | -2.39% | -15.20% |
12:22pm | Earnings Flash (XRAY) DENTSPLY SIRONA Posts Q1 Revenue $953M | MT |
12:22pm | Earnings Flash (XRAY) DENTSPLY SIRONA Reports Q1 EPS $0.42 | MT |
Strengths
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The firm trades with high earnings multiples: 22.99 times its 2024 earnings per share.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.20% | 6.27B | B- | ||
-3.43% | 184B | C+ | ||
-1.81% | 107B | C | ||
-4.15% | 67.52B | A | ||
+1.43% | 50.06B | B- | ||
+11.60% | 45.67B | B- | ||
+3.40% | 41B | B+ | ||
+3.03% | 26.73B | B | ||
+3.21% | 26.47B | A- | ||
+15.23% | 25.05B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XRAY Stock
- Ratings DENTSPLY SIRONA Inc.